Tg(hs1172-cre/ERT2,-GFP)606Jlr
Transgene Detail
|
|
| Symbol: |
Tg(hs1172-cre/ERT2,-GFP)606Jlr |
| Name: |
transgene insertion 606, John Rubenstein |
| MGI ID: |
MGI:6160954 |
| Synonyms: |
1172-CreER-IRES-GFP, Tg(NR2F1-cre/ERT2, GFP)606Jlr |
| Transgene: |
Tg(hs1172-cre/ERT2,-GFP)606Jlr Location: unknown
|
| Alliance: |
Tg(hs1172-cre/ERT2,-GFP)606Jlr page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(hs1172-cre/ERT2,-GFP)606Jlr expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| human |
hs1172 |
|
|
| |
|
Mutation details: This transgene contains the human enhancer element hs1172 -- which is flanked on human Chr 5 by the ARRDC3 [arrestin domain containing 3] antisense RNA 1 (ARRDC3-AS1) and NR2F1 [nuclear receptor subfamily 2 group F member 1] antisense RNA 1 (NR2F1-AS1) loci -- followed by a mouse minimal Hsp68 promoter, the cre/ERT2 fusion gene, an internal ribosomal entry site (IRES), and a green fluorescent protein reporter gene. The fusion gene encodes Cre recombinase joined to a modified ligand-binding domain of the human estrogen receptor that preferentially binds tamoxifen or 4-hydroxytamoxifen, but not endogenous 17beta-estradiol; upon binding to tamoxifen, the cre/ERT2 protein is translocated to the nucleus.
(J:214335)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
hs1172
(human)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:214335 Pattabiraman K, et al., Transcriptional regulation of enhancers active in protodomains of the developing cerebral cortex. Neuron. 2014 Jun 4;82(5):989-1003 |
| All: |
1 reference(s) |
|
Analysis Tools
